Comments
Loading...
Arbutus Biopharma (ABUS) Forecast
NewsEarningsArbutus Biopharma (ABUS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestArbutus Biopharma (NASDAQ:ABUS) Stock Quotes, Forecast and News Summary
Arbutus Biopharma Stock (NASDAQ: ABUS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arbutus Biopharma (ABUS) stock?
You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.
Who are Arbutus Biopharma (ABUS) competitors?
There are no as such competitors for Arbutus Biopharma.
What is the forecast, or price target, for Arbutus Biopharma (ABUS) stock?
Arbutus Biopharma has a consensus price target of $5.50.
What is the current price for Arbutus Biopharma (ABUS)?
The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $3.21 last updated December 23, 2024 at 11:35 AM EST.
Does Arbutus Biopharma (ABUS) pay a dividend?
There are no upcoming dividends for Arbutus Biopharma.
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is Arbutus Biopharma (ABUS) going to split?
There is no upcoming split for Arbutus Biopharma.
What sector and industry does Arbutus Biopharma (ABUS) operate in?
Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.